Geode Capital Management’s IN8bio INAB Stock Holding History
Bought
Maintained
Sold
Other funds holding INAB
6CM
SCM
BCM
VCM
VFT
OC
TCBWMS
Geode Capital Management's INAB Position: Q1 2026 in Review
Geode Capital Management increased its IN8bio (INAB) stake by 311% in Q1 2026, buying an estimated $126K and bringing the position to 86,239 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.
Geode Capital Management first reported a position in INAB in Q3 2022 and has held it in 15 quarters since. The position peaked at $331K in Q1 2024. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.
- Geode Capital Management held 86,239 shares of IN8bio worth $128K as of Q1 2026.
- Geode Capital Management bought 65,270 IN8bio shares in Q1 2026, an estimated $126K.
- IN8bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4066 holding.
- Geode Capital Management first reported a position in IN8bio in Q3 2022 and has held it in 15 quarters since.
- Geode Capital Management's IN8bio position peaked at $331K in Q1 2024.
- 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.